Nanopublications

Matches in Nanopublications for { ?s ?p "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 22 of 22 with 100 items per page.

assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP973890.RAvi-DjtUnIdZ13_wBToDww_KS8GZaOFTstDN5mzD17fI130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973890.RAvi-DjtUnIdZ13_wBToDww_KS8GZaOFTstDN5mzD17fI130_provenance.
NP973891.RApBP-81BNXR9BgJLLEo1DExDWqLIq4-P0GC2pXjV90xM130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973891.RApBP-81BNXR9BgJLLEo1DExDWqLIq4-P0GC2pXjV90xM130_provenance.
NP137901.RAlmWl0OZfi5Yyap5gMk4gYWsimnk0Am2s65JgDuju2Fk130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137901.RAlmWl0OZfi5Yyap5gMk4gYWsimnk0Am2s65JgDuju2Fk130_provenance.
NP137903.RArMNo8q-LEDvySW0q1ifpXksyN8c_r4GPfov_Al5xOww130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137903.RArMNo8q-LEDvySW0q1ifpXksyN8c_r4GPfov_Al5xOww130_provenance.
NP88954.RAHhVZFNGzL8N-2vPtrFCuCx2xjG86K3CkOZWTirZyO0w130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88954.RAHhVZFNGzL8N-2vPtrFCuCx2xjG86K3CkOZWTirZyO0w130_provenance.
NP713123.RAjcesbxOyKDeyM3L6Z1nwwTfJ92XGi-ohDLufm4OxMPw130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713123.RAjcesbxOyKDeyM3L6Z1nwwTfJ92XGi-ohDLufm4OxMPw130_provenance.
NP88958.RAwFIfKSHJZXOCX3kKcjaJLf41-mAxAtDuE5-AtU9R3tM130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88958.RAwFIfKSHJZXOCX3kKcjaJLf41-mAxAtDuE5-AtU9R3tM130_provenance.
NP980171.RAksx7K4sBej2bh8wT_thmnVZ8h8cCoxeycJk8WtN5pZk130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980171.RAksx7K4sBej2bh8wT_thmnVZ8h8cCoxeycJk8WtN5pZk130_provenance.
NP980174.RAj_9aw6cqNAR1yOAX5vAytyISZ28sNh1Pvhd3ZS1vQ8I130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980174.RAj_9aw6cqNAR1yOAX5vAytyISZ28sNh1Pvhd3ZS1vQ8I130_provenance.
NP980175.RAsCsciox3JYN77qH2qSxc7k37s28U9KRJSv14o4Itci8130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980175.RAsCsciox3JYN77qH2qSxc7k37s28U9KRJSv14o4Itci8130_provenance.
NP616857.RA2verYFd_ewsIwewPOKvhGs8SBti60t6yNgg30TNj77Q130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616857.RA2verYFd_ewsIwewPOKvhGs8SBti60t6yNgg30TNj77Q130_provenance.
NP616818.RAIpF9WcHqbrBF_K9XDrLzzgT5u2X45QO7rxysz1rAHog130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP616818.RAIpF9WcHqbrBF_K9XDrLzzgT5u2X45QO7rxysz1rAHog130_provenance.
NP980172.RAL67o08_IzYb8JDnGP_VNOsjCFAViWXc3uc0Jkwze8xY130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980172.RAL67o08_IzYb8JDnGP_VNOsjCFAViWXc3uc0Jkwze8xY130_provenance.
NP980173.RAE44wyLGD7du2NDpI_lYOf6FbpkXi5P0cWk-kzeCGOIY130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980173.RAE44wyLGD7du2NDpI_lYOf6FbpkXi5P0cWk-kzeCGOIY130_provenance.
NP973889.RA7_xJ1PKO0pyNrrwmXNEMfJbUPHKkFjzBdPw2-VhpyFY130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973889.RA7_xJ1PKO0pyNrrwmXNEMfJbUPHKkFjzBdPw2-VhpyFY130_provenance.
NP973892.RA3mHd2AfNRrZRdZrDEp9xv_wbdN41IZuvxsauCwWSZMo130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973892.RA3mHd2AfNRrZRdZrDEp9xv_wbdN41IZuvxsauCwWSZMo130_provenance.
NP973893.RA3ZMC9E25HhDXVaXqaLyAfrsOc1ASUMPDdN_JL5J0yGw130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP973893.RA3ZMC9E25HhDXVaXqaLyAfrsOc1ASUMPDdN_JL5J0yGw130_provenance.
NP713122.RA5twkxXMmYxa8tFojg5Rp7mHj8sE_lacrFU8mfAJbYw8130_assertion description "[PGC polymorphism with H. pylori infection increased risk of GU (OR 8.69; 95% CI 1.01-74.69), and AG (OR 11.12; 95% CI 1.37-90.84) or GC (OR 10.61; 95% CI 1.28-87.79) in a super-multiplicative manner.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP713122.RA5twkxXMmYxa8tFojg5Rp7mHj8sE_lacrFU8mfAJbYw8130_provenance.